Search Results - "Rodriguez‐Martinez, Carlos E."

Refine Results
  1. 1

    Exploratory analysis of the economically justifiable price of nirsevimab for healthy late‐preterm and term infants in Colombia by Buendía, Jefferson Antonio, Acuña‐Cordero, Ranniery, RodriguezMartinez, Carlos E.

    Published in Pediatric pulmonology (01-05-2024)
    “…Introduction Respiratory syncytial virus infection is the leading cause of lower respiratory infection globally. Recently, nirsevimab has been approved to…”
    Get full text
    Journal Article
  2. 2

    Risk and Protective Factors for Childhood Asthma: What Is the Evidence? by Castro-Rodriguez, Jose A., MD, PhD, Forno, Erick, MD, MPH, Rodriguez-Martinez, Carlos E., MD, MSc, Celedón, Juan C., MD, DrPH

    “…To summarize the principal findings on risk and protective factors for childhood asthma, we retrieved systematic reviews on these topics in children (aged 1 to…”
    Get full text
    Journal Article
  3. 3

    Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review by Castro-Rodriguez, Jose A, Rodriguez-Martinez, Carlos E, Ducharme, Francine M

    Published in Pediatric pulmonology (01-12-2018)
    “…Most international asthma guidelines recommend that children ≤5 years with asthma or recurrent wheezing be treated with daily low- moderate dose inhaled…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The relationship between inflammation and remodeling in childhood asthma: A systematic review by Castro‐Rodriguez, Jose A., Saglani, Sejal, RodriguezMartinez, Carlos E., Oyarzun, Maria A., Fleming, Louis, Bush, Andrew

    Published in Pediatric pulmonology (01-06-2018)
    “…Objectives We aimed to perform a systematic review of all studies with direct measurements of both airway inflammation and remodeling in the subgroup of…”
    Get full text
    Journal Article
  6. 6

    The cost‐utility of intravenous magnesium sulfate for treating asthma exacerbations in children by Buendia, Jefferson A., Acuña‐Cordero, Ranniery, RodriguezMartinez, Carlos E.

    Published in Pediatric pulmonology (01-10-2020)
    “…Introduction Although evidence supports the use of intravenous magnesium sulfate (MS) in asthma exacerbations, MS continues to be considered a second‐line drug…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Cost‐utility of omalizumab for the treatment of uncontrolled moderate‐to‐severe persistent pediatric allergic asthma in a middle‐income country by RodriguezMartinez, Carlos E., Sossa‐Briceño, Monica P., Castro‐Rodriguez, Jose A.

    Published in Pediatric pulmonology (01-09-2021)
    “…Objectives Although several randomized clinical trials performed in children 6 years and older with Omalizumab as add‐on therapy have reported improvements in…”
    Get full text
    Journal Article
  9. 9

    Predictors of severity in severe respiratory infection in children with COVID‐19 respiratory infection in a developing country by Beltran, Daniel Mauricio, Villamil Osorio, Milena, Fonseca, Sara Liliana Goyeneche, Restrepo‐Gualteros, Sonia M., Garcia, María José Rosero, RodriguezMartinez, Carlos E.

    Published in Journal of medical virology (01-02-2023)
    “…On March 11, 2020, the WHO declared the COVID‐19 pandemic. This name was given to the disease caused by the SARS‐CoV 2 virus at its outbreak in December 2019…”
    Get full text
    Journal Article
  10. 10

    Metered‐dose inhalers vs nebulization for the delivery of albuterol in pediatric asthma exacerbations: A cost‐effectiveness analysis in a middle‐income country by RodriguezMartinez, Carlos E., Sossa‐Briceño, Monica P., Castro‐Rodriguez, Jose A.

    Published in Pediatric pulmonology (01-04-2020)
    “…Objectives Although the benefits of albuterol delivered via metered‐dose inhalers with a spacer (MDI+S) have been increasingly recognized, the evidence…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    The use of ipratropium bromide for treating moderate to severe asthma exacerbations in pediatric patients in an emergency setting: A cost‐effectiveness analysis by RodriguezMartinez, Carlos E., Sossa‐Briceño, Monica P., Buendia, Jefferson Antonio

    Published in Pediatric pulmonology (01-12-2021)
    “…Objectives Although the efficacy of the addition of ipratropium bromide (IB) to short‐acting β2‐agonists (SABAs) for treating children with moderate to severe…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Genes, environment, and developmental timing: New insights from translational approaches to understand early origins of respiratory diseases by Gutierrez, Maria J., Perez, Geovanny F., Gomez, Jose L., RodriguezMartinez, Carlos E., Castro‐Rodriguez, Jose A., Nino, Gustavo

    Published in Pediatric pulmonology (01-10-2021)
    “…Over the past decade, “omics” approaches have advanced our understanding of the molecular programming of the airways in humans. Several studies have identified…”
    Get full text
    Journal Article
  16. 16

    When adherence and inhalation technique matter: Difficult‐to‐control pediatric asthma in low‐ to middle‐income countries by RodriguezMartinez, Carlos E., Sossa‐Briceño, Monica P., Sinha, Ian P.

    Published in Pediatric pulmonology (01-06-2021)
    “…Despite relatively recent advances in our understanding of the physiopathology of asthma and the availability of highly effective controller medications, such…”
    Get full text
    Journal Article
  17. 17

    Cost‐effectiveness analysis of phenotypic‐guided versus guidelines‐guided bronchodilator therapy in viral bronchiolitis by RodriguezMartinez, Carlos E., Nino, Gustavo, Castro‐Rodriguez, Jose A., Perez, Geovanny F., Sossa‐Briceño, Monica P., Buendia, Jefferson A.

    Published in Pediatric pulmonology (01-01-2021)
    “…Objectives Although recent evidence suggests that management of viral bronchiolitis requires something other than guidelines‐guided therapy, there is a lack of…”
    Get full text
    Journal Article
  18. 18

    Predictors of response to medications for asthma in pediatric patients: A systematic review of the literature by RodriguezMartinez, Carlos E., Sossa‐Briceño, Monica P., Castro‐Rodriguez, Jose A.

    Published in Pediatric pulmonology (01-06-2020)
    “…Objectives There has been no systematic review of studies aimed to predict differential responses to medication regimens for asthma controller therapies in…”
    Get full text
    Journal Article
  19. 19

    Dexamethasone or prednisolone for asthma exacerbations in children: A cost‐effectiveness analysis by RodriguezMartinez, Carlos E., Sossa‐Briceño, Monica P., Castro‐Rodriguez, Jose A.

    Published in Pediatric pulmonology (01-07-2020)
    “…Objectives Although a short course (ie, 3 to 5 days) of orally administered prednisolone is a common and widely accepted practice among clinicians for…”
    Get full text
    Journal Article
  20. 20